Loading chat...
NY S08367
Bill
Status
6/5/2024
Primary Sponsor
Brad Hoylman-Sigal
Click for details
AI Summary
-
Requires all insurance policies providing prescription drug coverage to cover FDA-approved or emergency-authorized antiviral COVID-19 therapeutics when prescribed by licensed healthcare providers, with no annual deductibles or coinsurance.
-
Applies to individual policies, group/blanket policies, and contracts issued by medical expense indemnity corporations, hospital service corporations, and health service corporations in New York.
-
Requires Medicaid (medical assistance) to provide antiviral COVID-19 therapeutics at no cost to enrollees.
-
Allows insurers and programs to require patients to use manufacturer or government programs offering free or reduced-cost antivirals before using insurance coverage.
-
Takes effect January 1 following enactment and applies to all policies and contracts issued, renewed, modified, altered, or amended on or after that date.
Legislative Description
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Last Action
referred to insurance
6/5/2024